chr1-27382511-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001330448.1(CD164L2):c.245C>A(p.Pro82Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000344 in 1,454,402 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001330448.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD164L2 | NM_001330448.1 | c.245C>A | p.Pro82Gln | missense_variant | 2/6 | ENST00000374030.3 | NP_001317377.1 | |
CD164L2 | NM_207397.5 | c.245C>A | p.Pro82Gln | missense_variant | 2/5 | NP_997280.2 | ||
CD164L2 | XM_011541441.2 | c.245C>A | p.Pro82Gln | missense_variant | 2/6 | XP_011539743.1 | ||
CD164L2 | XR_241190.4 | n.339C>A | non_coding_transcript_exon_variant | 2/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD164L2 | ENST00000374030.3 | c.245C>A | p.Pro82Gln | missense_variant | 2/6 | 5 | NM_001330448.1 | ENSP00000363142.1 | ||
CD164L2 | ENST00000374027.7 | c.245C>A | p.Pro82Gln | missense_variant | 2/5 | 1 | ENSP00000363139.3 | |||
CD164L2 | ENST00000374025.4 | n.312C>A | non_coding_transcript_exon_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 246380Hom.: 0 AF XY: 0.0000226 AC XY: 3AN XY: 132910
GnomAD4 exome AF: 0.00000344 AC: 5AN: 1454402Hom.: 0 Cov.: 31 AF XY: 0.00000554 AC XY: 4AN XY: 722546
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | The c.245C>A (p.P82Q) alteration is located in exon 2 (coding exon 2) of the CD164L2 gene. This alteration results from a C to A substitution at nucleotide position 245, causing the proline (P) at amino acid position 82 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at